Blossomhill Therapeutics (BLSM US)

Analysis

Health Care • United States

Blossomhill Therapeutics, Inc. is a biopharmaceutical company. The Company develops small molecule medicines that address unmet medical needs in cancer treatment. Blossomhill Therapeutics operates in the United States.

Refresh

Focused

No publications yet

There aren’t any sponsored reports right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00